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ABSTRACT
Identification of common sub-sequences for a group
of functionally related DNA sequences can shed
light on the role of such elements in cell-specific
gene expression. In the megakaryocytic lineage,
no one single unique transcription factor was
described as linage specific, raising the possibility
that a cluster of gene promoter sequences presents
a unique signature. Here, the megakaryocytic gene
promoter group, which consists of both human
and mouse 50 non-coding regions, served as a
case study. A methodology for group-combinatorial
search has been implemented as a customized
software platform. It extracts the longest common
sequences for a group of related DNA sequences
and allows for single gaps of varying length, as well
as double- and multiple-gap sequences. The results
point to common DNA sequences in a group of
genes that is selectively expressed in megakary-
ocytes, and which does not appear in a large
group of control, random and specific sequences.
This suggests a role for a combination of these
sequences in cell-specific gene expression in the
megakaryocytic lineage. The data also point to an
intrinsic cross-species difference in the organiza-
tion of 50 non-coding sequences within the mam-
malian genomes. This methodology may be used
for the identification of regulatory sequences in
other lineages.
INTRODUCTION
Functional regulatory elements for gene expression reside in
the genome in the form of short subsequences. In the majority
of the identiﬁed cases, these regulatory elements appear in
promoter regions upstream of gene coding sequences. They
are often recognized by transcriptional factors which activate/
suppress gene transcription. In some other cases, regulatory
elements appear in the 30-untranslated region of a gene, and
modulate the stability and translatability of the transcribed
message through protein factors, or through RNA molecules,
such as micro RNAs, as reviewed by Bartel (1). A recent
study by Xie et al. has shown the feasibility and signiﬁcance
of genome-wide analysis to extract common regulatory
elements conserved in several species (2). From a different
perspective, common-sequence analysis may also be applied
to identify common mechanisms governing the expression of
co-regulated genes.
This article presents a case study on the megakaryocytic
promoter group. Megakaryocytes are hematopoietic cells
that give rise to platelets, as discussed by Ravid et al. and
Shivdasani (3,4). During the differentiation of megakary-
ocytes, lineage-speciﬁc/selective activation of genes takes
place as reviewed by Kaluzhny (5). The following genes
are selectively co-expressed in megakaryocytes: the platelet
factor 4 (PF4) (6), glycoprotein IIb (GPIIb) (7), glycoprotein-
V (GPV) (8–10), glycoprotein VI (GPVI) (11) and c-Mpl
(12,13). The whole change in gene expression proﬁle is
important for megakaryocyte/platelet development and
function (3). However, the mechanism by which these
genes are all selectively expressed in megakaryocytes is not
fully understood. In other lineages of the hematopoietic
system, often genes expressed in the same lineage share a
common mechanism of control, such as common DNA bind-
ing sites to PU.1 factor in genes expressed in the myeloid
lineage as reviewed by Friedman (14). No unique, tissue-
selective transcription factor has been identiﬁed in the
megakaryocytic lineage. It is then reasonable to hypothesize
that there is a common mechanism underlying the
megakaryocyte-speciﬁc gene regulation, but this might rely
on a, yet unidentiﬁed, unique combination of common
sequences. In support of this contention, all megakaryocyte-
expressing genes are regulated by DNA binding sites to Ets
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doi:10.1093/nar/gkl578and GATA-1 transcription factors (6–13). However, it is not
clear whether these are the only factors regulating speciﬁc
gene expression in this lineage. Thus, the application of the
presented computational platform on this group of promoters
may help in identifying new regulatory sites and conﬁrming
already described ones.
A vast volume of work is reported in the literature of
Bioinformatics concerning analysis of DNA sequences,
focusing primarily on statistical methods (15–17), and
various statistical-scoring techniques, expressed in statistical
matrices [see also (18–22), http://www.npaci.edu/Press/98/
111898_webeng.html]. The methodology discussed in the
open literature commonly utilizes web-based platforms that
enable the user to develop applications based on computer
resources out of their control (15).
The development of ‘standalone workstations’ running
higher-level graphic and command interfaces to the com-
monly used BLAST suite of software was recently described
by Buisine and Chalmers (23). However, the implementation
reported is restricted to workstations running under the Unix
operating system, and limited to the capabilities of the
BLAST software.
Another platform available for the development of
customized applications is based on the BioMoby system
(http://www.biomoby.org). A tool built using BioMoby,
called Taverna (http://taverna.sourceforge.net) offers an
‘open source’ platform employing Web-based ‘Grid Compu-
ing’. It provides a graphic-user interface that enables one to
assemble whole process lines using services provided by
servers scattered over the internet without having to develop
any software.
The computational platform utilized for the current study
differs from the two customizable systems described above.
It focuses on a PC-based implementation that evolved in
response to the speciﬁc study described in this paper. A bat-
tery of algorithms were embedded in an interactive network
of graphic display and control screens, and interfaced with
a server-based database. These algorithms were designed to
extract common subsequences from a group of DNA samples,
extended to mono-gap sequences with a varying gap size. The
results for gap sizes varying between 0 and 10 elements are
utilized to identify common, double-gap segments, which
are further extended to identify long common multi-gap
sequences.
The hardware platform consists of a Personal-Computer
(PC)-based Workstation, which can be used in stand-alone
mode or as part of a server-controlled, distributed network
of PCs. Such platforms are commonplace in many research
and process laboratories. The software platform was origi-
nally developed for the design, implementation, operation
and teaching of manufacturing-process control networks, as
described by Hazony (24,25). It is particularly adept for
iterative development of customized applications, providing
a problem solving paradigm in which both problem speciﬁ-
cation and problem solution are concurrently reﬁned through
an iterative process. The present report describes such a
customized application. However, the platform can be easily
adapted for other purposes.
Finally, the false-positive-identiﬁcation (FPI) investiga-
tion, reported below, is based on two different methods:
one, using searches of randomized samples, and the second,
utilizing available bench-mark batches of 18406 samples,
each of 5000 elements upstream of genes (in relation the
ATG switch), extracted from the entire human genome
(http://genome-archive.cse.ucsc.edu/goldenPath/gh16/bigZips/),
and a corresponding batch of 14102 samples, each of 5000
elements upstream of genes, extracted from the entire murine
genome (http://genome-archieve.cse.ucsc.edu/goldenPath/
mm4/bigZips/).
The focus of this study has been to describe an application
of a computational platform that allows examination of the
hypothesis that genes selectively expressed in one hemato-
poietic lineage share a unique combination of regulatory
elements. Using the megakaryocyte as a model system, our
study identiﬁed a cluster of sequences that are unique to
gene promoters selectively active in this lineage. Within
these sequences, Ets and GATA binding sites were recog-
nized, imbedded in clusters of sequences highly selective to
megakaryocyte promoters, and for which mammalian binding
factors have not been identiﬁed yet. The ﬁndings validate our
unbiased search method for conserved regulatory elements
within a related group of genes, as Ets and GATA binding
sites have been previously described to regulate genes speci-
ﬁcally expressed in megakaryocytes. This method may be
also used for searching other groups of genes within and
out of the hematopoietic lineage.
MATERIALS AND METHODS
Hardware
The hardware platform used for this work consists of a cluster
of contemporary PCs running under the Windows-XP opera-
ting system and supported by a Windows-2000 Server
running on a separate machine. The communication is pro-
vided via Ethernet, which provides also rapid access to the
internet. Each machine is equipped with a 3 GHz Pentium4
processor and 1 Gb of high-speed memory (RAM). One PC
was upgraded to a RAM value of 3 Gb to accommodate the
extensive-temporary memory required for the full FPI runs
described above. All the work described in this article was
executed on this upgraded machine. However, some of the
exploratory studies beneﬁted from a ‘production-line’ mode
of operation afforded by the server-controlled cluster of
personal computers.
Software
The software platform used for the present work is an
adaptation of a server-controlled, distributed network of
PCs, developed for the design, implementation, operation
and teaching of manufacturing-process control. This is an
intranet-based conﬁguration, connected to the internet for
the purpose of database exchanges over the web as well as
for remote access to the system. The system is based on a
computational paradigm that has evolved in past several
decades in the context of CAD/CAM and Process Control.
In this computing paradigm the end user of the methodology
is totally divorced from the software via several layers of
‘user interfaces’ and tools for software automation (24,25).
This is accomplished employing a ‘network’ of utilities
such as textual and/or graphic control panels, popup
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mathematical tools, rule-based algorithms, and graphic data
mining and displays. Software customization is common-
place in this domain in the form of specialized controllers,
machines and processes and the end user is the beneﬁciary
of the customization but not necessarily its developer.
The speciﬁc platform used is equipped with extensive tools
for the study and implementation of process customization,
permitting the dual role of developer/user, where the user
can toggle back and forth, under software control, between
the two roles during application development. This capability
was utilized during the development of the software
employed in the ﬁnal version of the current study. The system
infrastructure, as well as its algorithmic components, are
implemented in the APL2 programming language, which is
available for most of the popular workstations and mainframe
computers.
The Megakaryocyte Group, Determination of Group-
Combinatorial Sequence Incidences (GCSI) and the
algorithms used
A total of nine megakaryocyte gene promoters (MegaKP)
were analyzed, including ﬁve human (hPF4, hGPV, hGPVI,
hGPIIB, hMpl) and four mouse (mPF4, mGPIIb, mGPV,
mMpl) sequences. The focus of analysis was on 5 kb
upstream to the ATG (sequences derived from GenBank) in
genes and species for which megakaryocyte-speciﬁc expres-
sion has been previously demonstrated to be driven by the
50 non-coding region (6–13). Intron and 30 non-coding regions
were not included in this computational search, as they have
not been demonstrated to be crucial for promoter activity for
any of the above genes. Moreover, this selection allowed
comparison of sequences equal in length and gene topo-
graphy. The goal has been to apply an algorithm to identify
within these segments sequences spaced by different gaps,
which might be selectively appearing in the megakaryocyte
group, as compared with random and other speciﬁc
sequences.
DNA segments are built on a combinatorial arrangement of
four elements represented by the letters A, C, G and T, and on
the complementary nature of the AT and CG pairing. Two
DNA segments of the same length are considered comple-
mentary if the elements of one segment are complementary
to the respective elements of the second segment in reverse
order, i.e. ACTG is complementary to CAGT. A compre-
hensive group-combinatorial scan of nine DNA samples,
associated with the MegaKP group, was performed, searching
for the common presence of all complementary pairs of
segments of length N, and the results are shown in the ﬁrst
row of the table depicted in Figure 1.
A rapidly-converging algorithm is employed, based on
a ‘tree-pruning’ approach, which reduces the search space
to a manageable size, while guarantying the completeness
of the search. The algorithm performs a concurrent-
comprehensive search for sequences of length N that are com-
mon to a group of related DNA samples. It starts scanning a
full combinatorial list for N ¼ 4, and eliminates entire tree
branches based on the absence of some short sequences
from this initial list. The reduced list serves as a starting
list for the derivation of the reduced combinatorial list for
sequences of length of N + 1. The iterative process proceeds
until reaching an N value for which the reduced list is empty.
A conceptually-similar algorithm was reported by Brazma
et al. (19). The merit of such an algorithm is emphasized
when the numeric values in the zero-gap row (Figure 1A)
are compared with the corresponding combinatorial values
of  0.5 · 4
N. The combinatorial-search algorithm
used retains also the upstream-starting location of each
individual occurrence of each member of the recorded-
segment list.
The results of a similar search algorithm for sequences that
include a single ‘gap’ are also shown in the corresponding
rows in the table depicted in Figure 1A, for gaps of lengths
between 1 and 10. The presence of a gap in a segment implies
that the search algorithm ignores the elements occupying the
respective gap locations. The numbers shown in the table
represent the number of incidences of at least one of each
complementary pair of length N, where N represents the
number of non-blank elements in a sequence. The header of
the table shown in Figure 1A indicates the length N of
sequences recorded in a particular column of the table, and
the gap-size column on the left indicates the single-gap size
recorded in the particular row of the table.
The total number of sequence-searches employed to reach
a certain column in a row, corresponding to a particular gap
(including 0), is obtained by summing up all preceding
numbers on the left. The tree-pruning algorithm used guaran-
tees a complete search. A direct link to the database is
embedded in the algorithm creating a structured archive
that includes all the data needed for a customized data-
mining process. These include data labels, sequence-
incidence records and the speciﬁc location for each
occurrence.
Figure 1A shows also the display/control panel of the
workstation, which includes the relevant experimental control
parameters, i.e. (i) Minimum sequence length—this deter-
mines which is the ﬁrst N value recorded in the database
supporting the display. This parameter does not affect the
execution of the algorithm but deﬁnes which of the data are
stored for further use and (ii) Lower frequency limit—this
parameter sets a minimal value for the number of occurrences
of a particular sequence in the sample being investigated to
qualify as a score in the GCSI table. The actual value used
in the present study is 1, meaning that the sequence scanned
occurs at least once in each of the samples belonging to the
selected group.
Electromobility shift assay
Y10L8057 megakaryocytic cells (6) were cultured in F-12
media (Invitrogen) supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin/streptomycin at 37 C. To
induce differentiation, cells were washed and resuspended
in IMDM media (Invitrogen) supplemented with 10%
FBS, 1% penicillin/streptomycin and 25 ng/ml thrombopoi-
etin and cultured for 2–3 days. As control, we used mam-
mary epithelial cells (NMuMG, ATCC CRL #1636) grown
as instructed by ATCC. Cells were washed 2· with ice
cold 1· phosphate-buffered saline (PBS), resuspended in
lysis solution (10 mM Tris–HCl, pH 7.6, 10 mM NaCl,
3 mM MgCl2, 0.5% NP-40), incubated on ice for 5 min,
centrifuged at 500· g for 5 min and then washed with
1 ml lysis buffer. Nuclei were resuspended in freezing
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EDTA, 40% glycerol) at  10
7 nuclei/100 mL and snap
frozen. An equal volume of NBP solution [20 mM Hepes,
pH 7.9, 0.4 M NaCl, 15 mM MgCl2, 0.2 mM EDTA,
25% glycerol, 0.5 mg/mL DTT supplemented with 1·
miniComplete  proteinase inhibitors cocktail (Roche)] was
added to the frozen nuclei and the extraction stirred gently
with a cut pipette tip and incubate on ice for 20 min. The
extraction was then centrifuged at 14K r.p.m. for 30 min
at 4 C and supernatant recovered. Protein concentration
determined using Bio-Rad protein assay kit. Extract aliquots
are stored at  80 C. Electromobility shift assay (EMSA)
was used to determine binding of nuclear proteins to oligo-
mers, as described in Lu et al. (6). Brieﬂy, samples con-
tained 20 mg of nuclear extracts, 5 mg poly(dI–dC)
(Amersham Biosciences), 1· binding buffer (10 mM
HEPES, pH 7.9, 1 mM DTT, 0.1% Triton-X, 0.5% glycerol)
and 5 ml of labeled oligo diluted 1:10 and incubated 0.5–1 h
at room temperature. Protein–DNA complexes were
resolved on a 4% native polyacrylamide gel [4% acry-
lamide, 1· TBE (90 mM Tris–Borate, 2 mM EDTA, pH
8.0), 0.6% ammonium persulfate, 0.06% TEMED] in 1·
TBE buffer at 130 V for  2.5 h. Gel was ﬁxed in solution
of 10% methanol, 10% acetic acid and dried on a gel dryer
(Biorad) and analyzed by autoradiography. The wild-type
oligo used was 50-AGCTACTTGNGAGGCCGAG-
GCAGGAGAATTGCTTGAA-30. The mutated oligo was
(note italic bases) 50-AGCTACTTGNGAGGCCGAGG-
CAGCATGTATGCTTGAA-30. As control to test the
nuclear extracts, assays were also performed using an Sp1
probe with the consensus site in bold) 50–CCGACTG-
CGGCCCCGCCCCTTAGAACGTTGTGACGTAGGAGC-
ATTCCACG-30. To anneal oligos 10 mg of each was boiled
for 5 min in 10 mM Tris, pH 8.0, and 10 mM MgCl2 fol-
lowed by gradual cooling to 4 C. Annealed oligos were
diluted 1:5 and labeled with [g-
32P]ATP using T4 polynu-
cleotide kinase (New England Biolabs) according to manu-
facturers protocol. Sample volume was brought to 100 ml
with STE (10 mM Tris–HCl, pH 7.8, 10 mM NaCl,
1 mM EDTA) and then run through a Sephadex G-50





Figure 1. (A) GCSI table for the 9-sample MegaKP group. The rows
correspond to single-gap sequences. Gap lengths vary between 0 and 10
elements, as indicated by the left-most column labeled as ‘Gap Size’. The
columns correspond to sequence length excluding the gap, as indicated by the
header row labeled as ‘String Size’. For example, the entry of the table
corresponding to gap-size of 4 and string-size of 9 contains 14 incidences of
sequences, each one consisting of two shorter sub-sequences separated by a
gap of four elements, while the sum of non-gap elements is nine. The top row
includes key-wards serving for storage and retrieval of these data in the
database. The bottom part of the figure includes lists of ‘commands’ on the
left and list of operational parameters on the right to illustrate the format of
pursuit with this application. (B) The GCSI table for the randomly scrambled
9 samples of the MegaKP Group. The layout of this figure is the same as in
(A). The contents of the figure changed in several ways. The entry in the
‘Type’ field in the top row has changed automatically to ‘RANDOM’
reflecting the fact that the derivation process started with a randomizing
algorithm. The ‘MIN SEQUENCE LENGTH’ parameter was changed to 5,
resulting in the first column of the GCSI table containing 5-element
sequences (excluding the gap). Finally, the longest common sequences found
are of lengths of seven elements (excluding the gap), depicting the impact of
the sample-randomization process. (C) The compressed-GCSI table for the 9-
sample MegaKP group. This figure varies from Figure 1A in the layout of the
bottom part, including the lists of commands available and the list of
operational parameters. Furthermore, the numeric contents of the Table
have changed as a result of the application of two compression algorithms
designed to remove redundancies in the table (see text). The ‘Lower-Length
Limit’ parameters will be used later to create a ‘pre-selected list’ of
sequences.
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Group-combinatorial sequence incidences search of
randomly scrambled samples
DNA sequences may be scrambled by re-indexing the
elements using randomized-index vectors. Results obtained
by applying the GCSI search to randomly scrambled samples
are shown in Figure 1B. Repeated application of this method
generates tables of varying contents but similar patterns. A
most signiﬁcant feature of the table is the entries in the last
column on the right, which in this particular case correspond
to string size of N ¼ 7. This last column may have few more
entries or be eliminated altogether in different randomization
runs. Similarly, the numerical values in the preceding
column, corresponding to string length of six, may vary and
the listing of the sequences would differ owing to the
randomization process involved.
The signiﬁcance of the data summarized in this table is
comparable with Figure 1A. The absence of entries in col-
umns 8–12 in Figure 1B contrasts with the structure displayed
in Figure 1A, suggesting that in the quest for sequences
unique to the particular group at hand (MegaKP) it is more
promising to focus on string lengths >7. A comparison of
the magnitude of the entries in this column, in both
tables, shows signiﬁcantly larger incidence values for the
non-scrambled table. The gross ratio between these values
suggests FPI indicators of the order of 25% for the sequences
recorded in column 7 of Figure 1B. Notice that in contrast
to Figure 1A, the leading column in the GCSI table shown
in Figure 1B corresponds to N ¼ 5. This selection is con-
trolled by the ‘min sequence length’ parameter deﬁned in
the parameter column shown at the bottom-right of the
screen. This selection does not affect the search speed but
rather the retrieval speed of archived data.
Compressed GCSI tables
Inspection of the contents of the GCSI table reveals subs-
tantial redundancy owing to two sources: (i) Horizontal
redundancy—any row in the table includes all combination
of sub-sequences derived from a longer sequence present
on the right side of the row and (ii) Back-Diagonal
redundancy—any sequence present at the top-right of the
table spawns sequences of same length but larger gaps,
which appear along back-diagonals of the table, extending
from top-right to bottom left.
Two algorithms are employed to remove the redundancy
from the data shown in Figure 1A, resulting in the com-
pressed GCSI table presented in Figure 1C. A similar table
is shown in Figure 2 for the 5-sample human subgroup of
the MegaKP group, followed by the table corresponding to
the 4-sample murine subgroup depicted in Figure 3. Note
that the ﬁrst column shown in Figures 2 and 3 corresponds
to (N ¼ 7) as in Figure 1A and C.
False-positive identification (FPI) indicators
The FPI indicators are used to sort out unique sequences as
candidates for further studies. These indicators are derived
using two different approaches: the ﬁrst based on the com-
parison with results obtained for ‘randomized samples’, as
discussed above. This method is reﬁned (optionally) by
scanning a pre-selected list of sequences against a large num-
ber, i.e. 1000, of randomized samples. In this case the FPI
value is determined by the ratio between the number of ran-
domized samples, which included the particular string, and
the number of samples used. The second approach is based
on ‘randomly selected samples’ out of large databases and
used as reference batches. Four reference batches were used
for the present study: (i) an 18406-sample batch of 5000
upstream elements each, taken from upstream regions of
genes (in relation to the ATG translation start) in the
human genome (http://genome-archive.cse.ucsc.edu/golden
Path/gh16/bigZips/); (ii) A 1000-sample-batch extracted
from the above batch taken at an equidistance sample separa-
tion of 18; (iii) A 14102-sample batch of 5000 upstream ele-
ments each, taken from upstream regions of genes (in relation
to the ATG translation start) in the murine genome (http://
genome-archive.cse.ucsc.edu/goldenPath/mm4/bigZips/) and
(iv) A 1000-sample-batch extracted from the above batch
(3) taken at an equidistance separation of 14. While both
methods are available within the platform developed for
this research, a conceptual difference between the two meth-
ods should be emphasized since they answer two different
questions.
The procedure applied to the second approach consists of
the following steps: (i) A candidate-sequence list is derived
from the data associated with a compressed GCSI table
(Figures 1C, 2 and 3). Note that each entry in the list consists
of a complementary pair. (ii) Sequences of low interest to the
present study, i.e. all mono- and dual-element repetitive
strings, may be eliminated for computational efﬁciency.
This optional step was made available in response to
experience-based intuitive suggestions by molecular biolo-
gists. (iii) Each entry in the derived-sequence list is scanned
against an available reference-sample batch, and each
reference sample which had at list one match of either of
the complementary pair is marked and (iv) The number of
matching-reference samples is summarized and compared
with the total number of samples in the respective reference
batch, yielding an FPI indicator. Only those of the candidate
sequences complying with a preset FPI Cap are retained.
The FPI-indicator table for the 9-sample MegaKP group
is depicted in Figure 4 derived using an FPI scan batch of
1000 human samples (#2) and for an FPI cap of 10%. It
was derived using a candidate list obtained from the data
associated with the compressed-GCSI table shown in
Figure 1C. The selection was made by automatically includ-
ing in the list all entries of the columns above and including a
pre-determined minimal-N value. This value is set by the
‘Lower-Length Limit’ parameter included in Figures 1C
and 2 above. The table depicted in Figure 4 was obtained
using a minimum-sequence length of 7 for the row corre-
sponding to a gap of zero, and a minimum length of 8 for
gaps of length between 1 and 10. These restrictions and the
selection rules outlined above were applied for computational
efﬁciency and for clarity of the displays.
The number of members of the reference batch, which
scanned positive for a speciﬁc sequence, is shown in the
third column of Figure 4. The FPI indicator assigned to a par-
ticular sequence is determined by the ratio between this value
and the number of samples in the speciﬁc reference batch
employed. The fourth column in Figure 4 includes the total
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score in the third column. A comparison between the num-
bers in the third and fourth columns indicates that only a frac-
tion of these sequences had multiple occurrences in the same
sample. It is based on the data associated with the
compressed-GCSI table shown in Figure 1C, and on an FPI
Cap of 10%. Inspection of the numbers appearing in the
third column of Figure 4 indicates that setting up an FPI
Cap of 2% would eliminate the entries in the table altogether.
An FPI-indicator table for the 4-samples murine compo-
nent of the MegaKP group, as depicted in Figure 5, is
based on the data associated with the compressed-GCSI
table shown in Figure 2. It was derived using the FPI-
reference batch of 1000 murine samples and an FPI Cap of
Figure 3. The compressed-GCSI table for the 5-sample human component of the MegaKP group. This figure varies from Figures 1C and 2 in the numeric
contents of the table and in the values of the operational parameters in the bottom right column.
Figure 2. The Compressed-GCSI Table for the 4-sample murine component of the MegaKP group. This figure varies from Figure 1C in the numeric contents of
the Table and in the values of the operational parameters in the bottom right column.
Nucleic Acids Research, 2006, Vol. 34, No. 16 44211%. The 20 sequences so obtained, shown in Figure 5, are
considered as unique to the murine component of the
MegaKP group within the FPI limit of 1%. A comparison
between columns 3 and 4 in the table indicates that all but
one of these incidences has more than one occurrence per
sample. In other words, raising the ‘minimal frequency
parameter’ from one to two would eliminate 19 out of the
20 entries in this table.
A similar table is shown for comparison for the 5-sample
human component of the MegaKP group. It was derived
using a dual-stage FPI scan, involving (i) the application of
the 1000-sample human-reference batch (#2) and applying
an FPI Cap of 1%, resulting in a reduced 59-member list,
as shown in Figure 6 and (ii) further reﬁnement of this
59-sequence list is obtained by scanning it against the larger
reference batch of 18 406 human samples (#1) and an FPI
Cap of 0.01%.
An FPI-indicator table for the 5-samples human com-
ponent of the MegaKP group, as depicted in Figure 6, is
based on the data associated with the compressed-GCSI
table shown in Figure 3. The 13 sequences so obtained,
shown in Figure 6, are considered as unique to the human
component of the MegaKP group, within the FPI limit of
0.01%. A comparison between columns 3 and 4 in the table
indicates that none of these incidences has more than one
occurrence per sample. In other words, raising the ‘minimal
frequency parameter’ from one to two would eliminate all
entries in this list.
Sequence-location diagrams, multi-gap sequences
The sequence-location data, associated with each of the
recorded incidences of the sequences listed in Figure 7, are
summarized graphically in Figure 8A for the promoter of
the human hGPV gene. The zero-reference point, correspond-
ing to the location of the ATG switch, is on the right end of
the Location axis, and the ‘upstream’ direction is pointing to
the left. The sequential numbers in the left column refer to the
sequences listed in Figure 7. However, the number of samples
used in this display is too large for the sequential ﬁrst column
to be readable. For better readability the number of samples
participating in such a display has to be reduced as is illus-
trated in Figure 8B. All the elements of a particular sequence
(excluding the gap) are marked in Figure 8A and B by
vertical-line segments. All sequences are represented in
reverse order to comply with the ‘upstream’ convention,
namely that the element nearest to the ATG switch is on
the right of the segment and the furthest one is on the left.
Figures 7 and 8 are included to illustrate the capabilities of
the computational platform in its present stage of develop-
ment. The combined representation of all sequences, selected
for hGPV as an example, is shown at the top row of
Figure 8A, representing a multi-gap sequence, extending
over a range of 258 elements, including multiple gaps. The
range covered spans between the limits of  1565 and
 1823 with respect to the ATG switch. The elements
corresponding to the multiple gaps in the combined sequence
are denoted by the character ‘N’. Exploration of the rele-
vant data for all other members of the human component of
the MegaKP group yields a distribution of these conserved
sequences over the upstream promoter regions (Supple-
mentary Figures A-1–B-6). Hence, the megakaryocyte
group of gene promoters contains a distinctive DNA signa-
ture that consists of a unique combination of sequences
(as in Figure 8C) that are spaced to different degrees in the
various megakaryocytic genes.
Identification of putative transcription factor binding
sites within the newly identified sequences that are
conserved in the MegaKP group
The cluster of conserved human sequences in all the
megakaryocyte group of genes was further subjected to a
search against a database of known transcription factor bind-
ing sites. Several known mammalian and non-vertebrate tran-
scription factors (for which the mammalian homologs have
not been characterized yet) were identiﬁed (Figure 8C).
These include GATA-1, Ets binding sites and Pax binding
Figure 4. The FPI indicator table for the 9-sample MegaKP group. This was analyzed with an FPI-reference batch of randomly selected 1000 human
samples, each of 5000 bases, and an FPI Cap of 10%. The FPI values are determined by the ratio between the entrees in the third column and the FPI reference
batch size.
4422 Nucleic Acids Research, 2006, Vol. 34, No. 16sites, which bind to Pax, a protein that also recognizes Ets
binding sites and alter Ets transactivating properties (26–
28); part of the mammalian Lymphocyte enriched DNA-
binding protein (Lyf-1) binding site, the Drosophila melan-
gaster Bicoid (Bcd) binding site, and the yeast Saccha-
romyces Cerevisiae heat shock factor, HSF, recognition site
(29–31). The Ets family of transcription factors has a DNA-
binding domain in common that binds a core GGA(A/T)
DNA sequence. Ets-1 was ﬁrst described as the cellular
homolog of v-Ets. Ets-2 was subsequently described as a clo-
sely related protein that contains the highly conserved Ets
DNA-binding domain. Our earlier studies and those of
other indicated that Ets as well as GATA binding sites are
important for activation of gene promoters that are uniquely
expressed in megakaryocytes (please refer to the Introduc-
tion). Moreover, it has been reported that the 50 non-coding
region in the human GPV contains closely spaced GATA
and Ets sites that are functionally active (32). The same
sites were identiﬁed in our computational quest as shown in
Figure 8C. Hence, our current ﬁndings highlight the value
of the search method employed here to identify regulatory
regions within any other groups of genes that is uniquely
expressed in one lineage. In addition, the search identiﬁed
new conserved sequences surrounding the Ets and GATA
sites, and these sequences are unique to the megakaryocyte
group. The only variable found between these clusters in all
Figure 6. A refined FPI scan for the human component of the MegaKP group. A pre-selected list was scan against the 1000 sample human-scan-batch to produce
the list shown in Figure 7, which then was scanned versus the 18 406-sample human-scan-batch and an FPI Cap of 0.01%.
Figure 5. The False-Positive-Identification (FPI) indicator table for the 4-samples murine component of the MegaKP group, with an FPI-reference batch of 1000
murine samples and an FPI Cap of 1%.
Nucleic Acids Research, 2006, Vol. 34, No. 16 4423the genes analyzed was the spacing between the conserved
sequences (indicated in Figure 8C by N). In some gene pro-
moters, such as GPV, the clusters are in close proximity,
while in other genes the distances are greater (see Supple-
mentary Material online). While Ets and GATA sequences
were already conﬁrmed binding sites in genes expressed in
megakaryocytes, the sequence G C T A C T T GNGAG
GCCGAGGCAGGAGAATTGCTTGAA
(Figure 8C) is the longest stretch that is perfectly identical
in all megakaryocytic genes and it has never been tested
for protein binding. Here, we used EMSA (Figure 9) to
demonstrate clear binding of megakaryocytic nuclear proteins
Figure 7. An FPI Scan of the 5-sample human component of the MegaKP group. A pre-selected list was scanned against the 1000-sample human scan batch and
an FPI Cap of 1%. Note that the majority of the entries in the third column of the table are zeros, indicating a better than 0.1% FPI values, which prompted the
more refined scan shown in Figure 6.
4424 Nucleic Acids Research, 2006, Vol. 34, No. 16to this oligomer (oligo) as well as to a similar oligo in which
the putative yeast heat shock factor binding site was mutated
(putative HSF site shown in Figure 8; AGAAT). As also
shown in Figure 9, no signiﬁcant binding was detected in
nuclear extracts prepared from epithelial cells (which was
previously tested for binding to a consensus Sp1 site as
detailed in the legend to Figure 9). Two complexes were
noted in nuclear megakaryocytic cells incubated with the
A
B
Nucleic Acids Research, 2006, Vol. 34, No. 16 4425wild-type oligo and these were competed by the cold oligo or
the mutated one. This suggested that the main binding is not
via this site (AGAAT), but rather via neighboring sequences.
Of note, upon mutation of the AGAAT site, binding of an
additional high molecular weight complex became possible,
which suggests that this domain represses binding of an addi-
tional protein(s). The identiﬁcation of the factors that bind to
the novel sequences identiﬁed in this study will be a focus of
future investigation.
Analyses of all genes, pursued as shown for GPV
(Figure 8), are illustrated in Supplementary Figures A-1–B-6.
For the mouse PF4 promoter, clusters of conserved
sequences are located within the ﬁrst Kilobase, but also
upstream to it (Figure A-2). Noted were conserved Ets
binding sites which correspond to those published as
functional, in addition to the conserved sequences, for
which mammalian transcription factor binding sites have
not been identiﬁed yet (6). In the human PF4 promoter all
the conserved sequences (the same as in Figure 8C for
hGPV) are concentrated around  2.5 kb (Figure B-2).
Another example is the GPIIb promoter. In this case, func-
tional Ets and GATA binding sites were described to reside
within  60–32 bases (with zero denoting the transcriptional
start) (7). In our search, the surrounding sequences of these
sites were not identiﬁed as unique to megakaryocytes (Sup-
plementary Figure A-4). The same conserved and unique to
this lineage clusters, which were identiﬁed and described
for GPV (the DNA signature shown in Figure 8C),
were also found in GPIIb, but they were spread with gaps
>1–4 kb in the case of mGPIIb and >1.7–5 kb in the case
of hGPIIb.
DISCUSSION
The merit of a customized system is in its ability to fulﬁll the
speciﬁc objectives of a particular research project. Two web-
based systems for customized application of Bioinformatics
have been described in the literature (23); and the Taverna
system http://www.biomoby.org; http://taverna.sourceforge.
net/. The methodology outlined in the present report was
developed to respond to speciﬁc research requirements, pro-
viding for the development and application of customized-
tool kits. Our choice of the customization approach may
reﬂect on the lack of sufﬁcient expertise and/or resources to
exploit the potential of available web-based methodologies,
while having access to expertise in the development of
customized-computer applications.
The objective of the present study was to identify unique
sequences, and clusters of sequences, common to a 9-member
MegaKP group, and to explore the associated sequence-
location information, which may shed light on the role played
by such sequences in regulating lineage-speciﬁc expressions.
Our methodology is outlined in the context of some of
the results obtained for the megakaryocytic gene promoter
group. The model employed has evolved through consecutive
C
Figure 8. (A) A location diagram for the hGPV sample and the 59-member list shown in Figure 7, based on an FPI Cap of 1%. The 59 individual sequences are
referred to by the index vector shown in the right column. The location of the ATG switch is at the right of the location scale (bottom), and the ‘upstream’
direction is pointing to the left. Note the overlapping location of all these sequences, as depicted on the ‘COMBINED’ line at the top of the picture. This multi-
gap sequence is 258-element long, as is detailed in panel (C). (B) A location diagram for the hGPV sample and the 13-member list shown in Figure 6, based on an
FPI Cap of 0.01%. (C) The cluster of combined-unique sequences shown in (A) for the promoter of the hGPV gene and identification of putative transcription
factor binding sites. The number of participating segments is 59 and the FPI Cap used is 1%. The gaps are indicated by ‘N’ elements. The leading non-N element
(first ‘G’ in left of top row) is located at position -1830 upstream from the ATG switch, and the last non-N element (rightmost ‘G’ in bottom row) is located at
position  1551 upstream from the ATG switch. This 258-element, multi-gap sequence contains sequences that are uniquely common to all the megakaryocyte
expressing genes. This stretch was also searched for transcription factor binding sites using the web-based TFSEARCH program, developed by Yutaka
Akiyama (http://www.cbrc.jp/research/db/TFSEARCH.html) searching in all matrices (vertebrate, arthropod, plant and yeast) with a homology threshold of 90%
or more. The program searches highly correlated sequence fragments against TFMATRIX transcription factor binding site profile database in the ‘TRANSFAC’
databases developed by Heinemeyer et al. (33). Core nucleotides of Ets transcription factors were also identified using the ‘find’ function on MacVector6.5.3 
(Accelrys, San Diego, CA).
4426 Nucleic Acids Research, 2006, Vol. 34, No. 16simple conceptual steps: (i) a simple model was initially
implemented, consisting of a search for contiguous segments
common to the entire group of sample; (ii) an extension of
the searches to include single-gap sequences; (iii) an exten-
sion to searches for the common presence of variable-single-
gap sequences; (iv) identiﬁcation of common multi-gap
sequences; (v) further extension of segment alignment
through the addition/deletion of a small number of elements
and (vi) a contemplated extension to include a search for
‘closely placed active sites’, as reported by Lepage et al.,
allowing for a variable separation between the sites (32).
The results presented in this report indicate that, when
applied to the full MegaKP group, including both human and
murine samples, the observed common sequences correspond
to FPI indicators of the order of 10%. However, splitting the
study into the murine and human subgroups, results in an
observed FPI-indicator Cap of 1% for the murine sub-group,
while the human sub-group yielded a list characterized by
FPI-indicatorCapaslowas0.01%.Thesegroupsofsequences,
which are primarily present in genes that are expressed selec-
tively in the megakaryocytic lineage, are high candidates for
regulatory domains. Hence, our study suggests the existence
of a DNA signature that consists of a unique combination of
binding sites in the megakaryocytic, and provides a list of can-
didate sequences for future mutation studies to examine their
functional signiﬁcance individually and in combination. The
list of combination of sequences to potentially mutate for pro-
moteractivitystudiesislargeanditsavailabilitytotheresearch
community allows full examination of these regions.
It should be emphasized that the development of a PC-
based customized platform does not preclude complementary,
web-based studies. Of most interest, when the newly identi-
ﬁed human sequences were subjected to a web-based search
against a database of known binding sites for transcription
factors, several putative Ets binding sites were identiﬁed.
Additional clusters of sequences were identiﬁed, for which
binding factors have not been identiﬁed yet, e.g. the mamma-
lian homolog of the yeast HSF (Figure 8C). When the murine
conserved sequences in the megakaryocyte group (Figure 7)
were similarly searched against the same databases, the Ets
binding core was identiﬁed in sequence # 17 and HSF puta-
tive sites were recognized in sequences # 1 and 14 (Figure 7).
These ﬁndings further validate our unbiased search method
for conserved regulatory elements that might be signiﬁcant
within a related group of genes, as Ets biding sites have
been previously described to regulate genes speciﬁcally
expressed in megakaryocytes (see Introduction). This search
could be applied in the future to identify potential regulatory
elements in other groups of genes related by virtue of their
unique expression in a speciﬁc lineage.
The power of a methodology is manifested in having the
ﬂexibility to recognize and pursue new research venues
based on the unique sequences identiﬁed. The mechanism
and implication of such a characteristic difference between
the human and mouse groups are not clear at the moment.
Nevertheless, it raises an interesting possibility that there
exists an intrinsic difference in the organization of upstream
regulatory regions between the two mammalian genomes and
that the human megakaryocyte-speciﬁc genes are commonly
requested by a direct, or indirect, activation of the uniquely
shared sequences identiﬁed in this study.
The usefulness of a methodology is demonstrated through
the achievement and publication of meaningful scientiﬁc
results, which is the main purpose of the present paper. The
validity of its application is proven via the identiﬁcation of
clusters of common sequences in a group of genes related
by their speciﬁc expression in the lineage. These sequences
have been identiﬁed here for the ﬁrst time.
Comment: The evolving software is available from the
authors on request.
SUPPLEMENTARY DATA
Supplementary data are available at NAR online.
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